Diligence memo · auto-generated · as of July 3, 2026

Acclivity Health Solutions, Inc.

Acclivity Health Solutions, Inc. looks over-valued against its niche peers and is at-risk on financing cadence.

WatchOverdue for a raise versus sector cadence — could be a bridge, a down round, or distress. Watch for the next filing.

Businessfiled

Acclivity Health Solutions, Inc. operates in Healthtech, based in JACKSONVILLE.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Acclivity Health Solutions, Inc. has raised $21M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $13M on 2022-07-30.

Most recent recorded round closed around 2022-07-30.

Valuation (modeled)modeled

Provath models Acclivity Health Solutions, Inc. at approximately $135M (range $17M–$455M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 3.24× the median modeled value of Series A Healthtech companies in 2022–2024 (190 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 9 months.

Last raise 3.9 yr ago; this sector typically re-raises about every 14 months.

Past due for a raise versus sector cadence — watch for distress or a bridge.

The last round stepped up 4.7× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 81% of Healthtech peers (2138 compared).

Modeled value ranks above 82% of those peers.

Closest niche peers: Nayya Health, Inc., Nue Life Health Inc., W Health Studio, Inc., Avant-garde Health, Inc., Kinetik Healthcare Solutions, Inc.

Peoplefiled

11 named people on file across officers, directors and signatories.

Risks & flagsmixed

Overdue for a raise versus sector norm — distress or bridge risk.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.